-
Pipendoxifene (INN;
developmental code ERA-923) is a
nonsteroidal selective estrogen receptor modulator (SERM) that was
under development by
Ligand Pharmaceuticals...
- 45-0320 NNC 45-0781 NNC 45-1506
Ormeloxifene Ospemifene Panomifene Pipendoxifene Promensil Raloxifene Rimostil (P-081)
Spironolactone SS1010 Tamoxifen...
- miproxifene, nafoxidine,
nitromifene (CI-628), NNC 45-0095, panomifene,
pipendoxifene (ERA-923), trioxifene, and
zindoxifene (D-16726).
Sivifene (A-007) was...
-
member of the 2-phenylindole
group of SERMs,
along with
zindoxifene and
pipendoxifene. The drug was
approved in the
European Union by the
European Medicines...
- 45-0320 NNC 45-0781 NNC 45-1506
Ormeloxifene Ospemifene Panomifene Pipendoxifene Promensil Raloxifene Rimostil (P-081)
Spironolactone SS1010 Tamoxifen...
- 45-0320 NNC 45-0781 NNC 45-1506
Ormeloxifene Ospemifene Panomifene Pipendoxifene Promensil Raloxifene Rimostil (P-081)
Spironolactone SS1010 Tamoxifen...
-
receptor modulators (SERMs) that
includes zindoxifene, bazedoxifene, and
pipendoxifene, as well as the
nonsteroidal estrogen D-15414 (the
major metabolite...
- miproxifene, nafoxidine, nitromifene, ormeloxifene, ospemifene, panomifene,
pipendoxifene, raloxifene, tamoxifen, toremifene, trioxifene, zindoxifene, zuclomifene...
- 45-0320 NNC 45-0781 NNC 45-1506
Ormeloxifene Ospemifene Panomifene Pipendoxifene Promensil Raloxifene Rimostil (P-081)
Spironolactone SS1010 Tamoxifen...
- 45-0320 NNC 45-0781 NNC 45-1506
Ormeloxifene Ospemifene Panomifene Pipendoxifene Promensil Raloxifene Rimostil (P-081)
Spironolactone SS1010 Tamoxifen...
